Oramed’s oral insulin capsule, (ORMD-0801), was well tolerated by patients and no serious adverse events were observed. The insulin absorption was not affected when given before meal ingestion. Oramed the developer reported positive results from a Phase 2A study of its oral insulin capsule, ORMD-0801, on Type 1 diabetic patients. …

Black and Hispanic women in their 20’s tend to accumulate more fat in their midsection than their male and older counterparts, possibly putting them at a greater risk of developing Type 2 diabetes, new research suggests. See This Week’s Item #4

Over the past couple of years there have been studies released and commentaries written about the detrimental effects of tight glycemic control. The studies seem to say tight control is not good, yet the practitioners say it is. Now, in the July 27, 2009, issue of the Archives of Internal …

  Near-normal control of glucose beginning as soon as possible after diagnosis would greatly improve the long-term prognosis of Type 1 diabetes, concludes a study published in the July 27, 2009, issue of the Archives of Internal Medicine, which updates information about the clinical course of Type 1 diabetes.

Children with Type 1 diabetes are more likely to be overweight than their counterparts without Type 1 diabetes, researchers have found.

Although a pay-for-performance program introduced in family practices in the United Kingdom resulted in short-term improvements in care, the rate of gain was not sustained, researchers found.

Researchers warn that midsection weight gain could increase their risk of Type 2 diabetes. 

A team of Canadian scientists have discovered that naringenin, a flavonoid found in citrus fruit, and especially grapefruit, makes the liver burn fat instead of storing it after a meal. (This chemical compound also gives grapefruit its bitter taste.) Potentially, without having to change diets or cut out particular foods, …

The National Changing Diabetes((R)) Program (NCDP), a program of Novo Nordisk, and several member associations recently urged President Obama and members of Congress to make the prevention, detection and treatment of diabetes, one of the nation’s most pervasive and costly diseases, a priority in reforming the U.S. healthcare system.

Researchers have found that the damaging substance begins showing up well before diabetes begins and rises along with blood sugar as the disease progresses. This may be a new target to provide a possible cure for Type 2 diabetes.